IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, today announced that it is actively evaluating certain strategic ...

Products containing mainly or only cannabidiol demonstrated almost no ability to manage a person's pain, a review of clinical ...

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose and ...

Aetna agreed in a landmark legal settlement to cover fertility treatments for same-sex couples the same way as it does for ...

RECOGNIZING AND IMPROVING KNOWLEDGE OF MEDICAL USES OF MARIJUANA AND CANNABIDIOL FOR PATIENTS AND DOCTORS: Today, President Donald J. Trump signed an ...

The global cannabidiol oil market size was US$ 3.57 billion in 2021. The global cannabidiol oil market is forecast to grow to US$ 16.3 billion by 2030 by registering a compound annual growth rate ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) ('Artelo” or the 'Company”), a clinical-stage pharmaceutical company focused on ...

Key Takeaways CBD hasn’t been shown to help relieve chronic painClinical trials have shown no effect from CBD on pain, an ...

While users may think that rescheduling marijuana to Schedule III will legalize the drug, Trump is focusing on the research ...

Products with THC reduced pain a little across multiple trials, but those that were mostly CBD didn't outperform placebos.

Marijuana may soon be rescheduled, and the biggest change could be taxes. Here’s how reclassification could lower tax bills ...